TG Therapeutics Inc (TGTX)
- Exchange
- NASDAQ
- Symbol
- TGTX
- Sector
- Life Sciences
- Industry
- Pharmaceutical Preparations
- Description
- TG Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. The company is headquartered in New York, New York.
- Country
- USA
Stock price
At close: July 18, 2025
-
Open39.43
-
High39.54
-
Low37.66
-
Close37.91
-
Volume1,794,130
Financial ratios
Dec 31, 2024